Department of Health



South Dakota Department of Health - Newborn Screening


The Office of Lifespan Health is adding three new conditions, Duchenne Muscular Dystrophy, Mucopolysaccharidosis Type I (MPS I), and Mucopolysaccharidosis Type II (MPS II), to the required tests under the newborn screening program based on nomination, review, recommendation, and approval by the state's newborn screening nomination committee and the newborn screening advisory committee.

New content is added below as the draft rules move through the rule-making process.







Important Dates
Public Hearing:
Comment Deadline:
Interim Rules Committee Hearing:
Filed-Secretary of State:
Rule Effective:
09/23/2026
10/03/2026
10/14/2026

Agency Contact: Cassandra Deffenbaugh mail to: DOHAdminRules@state.sd.us